Part Two: The MFN Drug Pricing Rule and the Rebate Rule: Where Do We Go From Here?
Wiley Podcasts
December 11, 2020
In part two, Health Care partners Dot Powell-Woodson and Rachel Alexander continue their discussion of the Most-Favored Nations (MFN) Rule and the Rebate Rule and look at the potential impacts of these Final Rules on managed care companies.
Our Site uses cookies to improve your experience. Cookies may collect your personal information, such as IP address or device identifier, which we may disclose to our analytics partners. You may opt out of the cookies that are not strictly necessary if you wish. By using this site, you agree to our updated Privacy Policy, Terms & Conditions, and Cookies Policy.
Cookie Preference Center
Your Privacy
When you visit our website, we use cookies on your browser to collect information. The information collected might relate to you, your preferences, or your device, and is mostly used to make the site work as you expect it to and to provide a more personalized web experience. For more information about how we use Cookies, please see our Privacy Policy.
Strictly Necessary Cookies
Always Active
Necessary cookies enable core functionality such as security, network management, and accessibility. These cookies may only be disabled by changing your browser settings, but this may affect how the website functions.
Functional Cookies
Always Active
Some functions of the site require remembering user choices, for example your cookie preference, or keyword search highlighting. These do not store any personal information.
Form Submissions
Always Active
When submitting your data, for example on a contact form or event registration, a cookie might be used to monitor the state of your submission across pages.
Performance Cookies
Performance cookies help us improve our website by collecting and reporting information on its usage. We access and process information from these cookies at an aggregate level.